US Broker Ratings

Immunocore Holdings plc (IMCR) Stock Analysis: Exploring the 94% Potential Upside in a Robust Biotech Portfolio

Immunocore Holdings plc (NASDAQ: IMCR), a pioneering entity in the field of biotechnology, continues to capture the attention of investors with its impressive 94.22% potential upside...

BioCryst Pharmaceuticals, Inc. (BCRX) Stock Analysis: A Strong Buy with 137.65% Potential Upside

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) is making waves in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. Headquartered in Durham, North Carolina,..

Evolent Health, Inc. (EVH) Stock Analysis: Robust Revenue Growth and a 56% Potential Upside Draws Investor Attention

Evolent Health, Inc. (NASDAQ: EVH), a player in the healthcare sector specializing in health information services, is currently drawing investor interest with its notable revenue growth..

Mirum Pharmaceuticals, Inc. (MIRM) Stock Analysis: A 50% Potential Upside in the Biotech Sector

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) is capturing the attention of investors with its compelling growth potential in the biotechnology industry. Specializing in novel therapies for rare..

Kestra Medical Technologies (KMTS): Investor Outlook with a Strong Potential Upside of 22.27%

Kestra Medical Technologies, Ltd. (NASDAQ: KMTS), a key player in the medical instruments and supplies industry, has been making waves in the healthcare sector with its..

CRISPR Therapeutics AG (CRSP) Stock Analysis: Unveiling a 50% Potential Upside in Gene-Editing Innovations

CRISPR Therapeutics AG (NASDAQ: CRSP), a pioneer in the biotechnology sector, stands out as a beacon of innovation in the realm of gene editing. Based in..

Establishment Labs Holdings Inc (ESTA) Stock Analysis: A 51% Upside Potential Awaits Investors

For investors seeking exposure in the healthcare sector, particularly within the medical devices industry, Establishment Labs Holdings Inc. (NASDAQ: ESTA) presents a compelling opportunity. With a..

Mineralys Therapeutics, Inc. (MLYS) Stock Analysis: A Promising 71% Upside Potential in Biotech

Investors with an eye on the biotechnology sector should turn their attention to Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a burgeoning force in the healthcare industry. With..

ANI Pharmaceuticals, Inc. (ANIP) Stock Analysis: Unpacking a 37.44% Potential Upside

Investors eyeing the healthcare sector might find ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) an intriguing opportunity, especially given its promising potential upside of 37.44%. As a player..

Opko Health, Inc. (OPK) Stock Analysis: Exploring a Potential 158.88% Upside in Diagnostics & Research

Opko Health, Inc. (NASDAQ: OPK) is making waves in the healthcare sector, particularly for those investors with an eye on the diagnostics and research industry. With..

10x Genomics, Inc. (TXG) Stock Analysis: Navigating Potential Amidst a 52-Week High

10x Genomics, Inc. (NASDAQ: TXG) is capturing investor attention as the company’s stock sits at the upper end of its 52-week range, recently hitting $79.10. This..

Omnicell, Inc. (OMCL) Stock Analysis: Robust Growth Potential with 78% Upside

Omnicell, Inc. (NASDAQ: OMCL), a prominent player in the healthcare technology sector, is making waves with an impressive potential upside of 78.41% according to analysts. With..

Viridian Therapeutics, Inc. (VRDN): Biotechnology Stock with a 69.72% Potential Upside

Viridian Therapeutics, Inc. (NASDAQ: VRDN) has captured the attention of investors in the biotechnology sector with its robust pipeline and substantial growth potential. With a current..

GRAIL, Inc. (GRAL) Stock Analysis: Navigating the Diagnostic Sector with a 25.7% Revenue Growth Trajectory

GRAIL, Inc. (NASDAQ: GRAL), a key player in the healthcare sector, is making significant strides with its innovative approach to cancer diagnostics and research. With a..

Healthcare Services Group, Inc. (HCSG) Stock Analysis: Evaluating a 26.76% Potential Upside in the Healthcare Sector

Healthcare Services Group, Inc. (NASDAQ: HCSG) presents an intriguing proposition for investors looking to capitalize on the healthcare sector’s growth, particularly within the niche of medical..

Evotec SE (EVO) Stock Analysis: Exploring a 176% Potential Upside in the Healthcare Sector

For investors seeking opportunities in the dynamic healthcare sector, Evotec SE (EVO) presents a compelling case. Headquartered in Hamburg, Germany, Evotec SE operates as a drug..

Alvotech (ALVO) Stock Analysis: A 15.65% Potential Upside in the Biosimilar Market

Alvotech (ALVO), a Luxembourg-based company specializing in the development and manufacturing of biosimilar medicines, presents an intriguing opportunity for investors in the healthcare sector. Despite the..

PGIM Securitized Income ETF (PINC): A Stable Investment Amidst Volatile Markets?

Investors seeking stability in the unpredictable world of securities might find the PGIM Securitized Income ETF (NYSE: PINC) a compelling option. With a market capitalization of..

Structure Therapeutics Inc. (GPCR) Stock Analysis: Exploring a Biotech with a 187% Potential Upside

Structure Therapeutics Inc. (NASDAQ: GPCR) is making waves in the healthcare sector with its innovative approach to addressing chronic diseases through oral small molecule therapeutics. With..

Phreesia, Inc. (PHR) Stock Analysis: Exploring a 38.96% Potential Upside in the Healthcare SaaS Sector

Phreesia, Inc. (PHR), a key player in the healthcare industry, is garnering significant attention from investors due to its promising growth potential and strategic positioning within..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds